
DocMed is the technology investment and development arm of Hyphens Pharma International Limited, Singapore's leading specialty pharmaceutical and consumer healthcare group. We invest and develop digital healthtech solutions to empower various healthcare stakeholders in Singapore and the region. Our business dovetails with the Group's existing digital assets in Pan-Malayan Pharmaceuticals, namely POM, Singapore's leading online B2B medical hypermart, and WellAway, Singapore's first and only HSA-registered e-pharmacy.
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.